These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33007358)
1. Serotonin research: Crossing scales and boundaries. Di Giovanni G; De Deurwaerdère P Neuropharmacology; 2020 Dec; 181():108340. PubMed ID: 33007358 [TBL] [Abstract][Full Text] [Related]
2. [The pharmacological basis of the serotonin system: Application to antidepressant response]. David DJ; Gardier AM Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704 [TBL] [Abstract][Full Text] [Related]
4. Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. Murphy DL; Andrews AM; Wichems CH; Li Q; Tohda M; Greenberg B J Clin Psychiatry; 1998; 59 Suppl 15():4-12. PubMed ID: 9786305 [TBL] [Abstract][Full Text] [Related]
5. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Marek GJ; Carpenter LL; McDougle CJ; Price LH Neuropsychopharmacology; 2003 Feb; 28(2):402-12. PubMed ID: 12589395 [TBL] [Abstract][Full Text] [Related]
6. Serotonin: it's possible to have too much of a good thing. Stahl SM J Clin Psychiatry; 1997 Dec; 58(12):520-1. PubMed ID: 9448653 [No Abstract] [Full Text] [Related]
7. Serotonin receptors--where are they going? Leonard BE Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():7-17. PubMed ID: 8021439 [TBL] [Abstract][Full Text] [Related]
13. Medications acting on the serotonergic system for the treatment of alcohol dependent patients. Kenna GA Curr Pharm Des; 2010; 16(19):2126-35. PubMed ID: 20482508 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. Stahl SM J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979 [TBL] [Abstract][Full Text] [Related]
15. Recent Developments on Future Antidepressant-related Serotonin Receptors. Amidfar M; Kim YK Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919 [TBL] [Abstract][Full Text] [Related]
17. New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders. Ohno Y Cent Nerv Syst Agents Med Chem; 2010 Jun; 10(2):148-57. PubMed ID: 20518729 [TBL] [Abstract][Full Text] [Related]
18. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
19. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Blier P; de Montigny C Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353 [TBL] [Abstract][Full Text] [Related]
20. Computational approaches to the design of novel 5-HT6 R ligands. Ivanenkov YA; Majouga AG; Veselov MS; Chufarova NV; Baranovsky SS; Filkov GI Rev Neurosci; 2014; 25(3):451-67. PubMed ID: 24867282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]